Chronic prostatitis
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
20
|
1
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2017 |
QT interval feature (observable entity)
|
phenotype |
|
Clinical Attribute
|
75
|
226
|
0.100 |
None |
1.000 |
2 |
1
|
2009 |
2014 |
Progressive sensorineural hearing impairment
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
78
|
28
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Anhedonia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
93
|
7
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Phyllodes Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
100
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Glucocorticoid Receptor Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
104
|
12
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Vesicular Stomatitis
|
disease |
Infections; Stomatognathic Diseases; Animal Diseases
|
Disease or Syndrome
|
112
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Measles
|
disease |
Infections
|
Disease or Syndrome
|
113
|
6
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Giant Cell Tumor of Bone
|
disease |
Neoplasms
|
Neoplastic Process
|
113
|
3
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinoma, Neuroendocrine
|
disease |
Neoplasms
|
Neoplastic Process
|
182
|
7
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Varicosity
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
188
|
51
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Febrile Convulsions
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
192
|
65
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
PACHYONYCHIA CONGENITA 3
|
disease |
|
Disease or Syndrome
|
209
|
20
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Prostatic Intraepithelial Neoplasias
|
disease |
Neoplasms
|
Neoplastic Process
|
230
|
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Familial lichen amyloidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
230
|
24
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Nodule
|
phenotype |
|
Acquired Abnormality
|
278
|
19
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Headache
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
338
|
75
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2017 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2017 |
Fibroid Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
413
|
14
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2012 |
Encephalopathies
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
457
|
64
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
491
|
20
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Uterine Fibroids
|
group |
Neoplasms
|
Neoplastic Process
|
569
|
154
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2017 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |